Igen Will Boost Bio-Defense Product Line With Salmonella, E. Coli POC Tests
This article was originally published in The Gray Sheet
Executive SummaryIgen will seek FDA 510(k) clearance for an expanded infectious disease test menu following the introduction of a new point-of-care instrument
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.